• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

ObsEva - Articles and news items

pregnancy

ObsEva Phase II trial shows meaningful increase in pregnancy and live birth rates

Industry news / 28 October 2016 / Niamh Louise Marriott, Digital Content Producer

The results of ObsEva’s trial of OBE001 (nolasiban) showed improvement in clinical pregnancy and live birth rates in women undergoing embryo transfer…

nipt pregnancy

Time to address the unmet need in women’s reproductive health

Blog, Z Homepage promo / 20 September 2016 / Ernest Loumaye, MD, PhD, Co-Founder & Chief Executive Officer, ObsEva

Ernest Loumaye, PhD, Co-Founder & Chief Executive Officer of ObsEva discusses the unmet need of women’s reproductive health and what’s in the pipeline for treatment…

A premature newborn just after a c-section is cleaned up and prepped for the incubator shown in the background.

ObsEva initiates Phase 1 clinical program of OBE022 for the treatment of preterm labor

Industry news / 28 July 2016 / ObsEva

ObsEva initiates Phase 1 clinical program of OBE022, a first-in-class orally active Prostaglandin F2alpha antagonist, for the treatment of preterm labor…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionWATCH NOW
+ +